COURTNEY NELSON: Open Payments
NPI 1760188148 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 20 payments from 7 companies in 2025. Trend: 2023 $289 · 2024 $731 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $385 |
| Madrigal Pharmaceuticals | 2 | $63 |
| GENZYME CORPORATION | 2 | $49 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
Products named: RINVOQ, CREON, DUPIXENT, REZDIFFRA, SKYRIZI, ZENPEP, ENTYVIO, VELSIPITY.
Industry payments across OR — which companies pay providers there.
